51. Novel CircRNAs in Hub ceRNA Axis Regulate Gastric Cancer Prognosis and Microenvironment
- Author
-
Song Liu, Wenxian Guan, Qiongyuan Hu, Yuxiang Dong, Feng Sun, Xuefeng Xia, Ping Liu, Xianghui Li, Zhiyan Li, and Shichao Ai
- Subjects
Medicine (General) ,Tumor microenvironment ,ceRNA axis ,Competing endogenous RNA ,Regulatory T cell ,gastric cancer ,immunosuppressive microenvironment ,Cancer ,General Medicine ,Tumor-associated macrophage ,Biology ,medicine.disease ,R5-920 ,medicine.anatomical_structure ,novel circular RNA ,Circular RNA ,microRNA ,medicine ,Cancer research ,Medicine ,FLNA ,Immunotherapy ,Original Research - Abstract
Gastric cancer (GC) is one of the most prevalent malignancies with an unfavorable survival rate. Immunotherapy may contribute to a better prognosis. However, several phase III trials failed. Circular RNA (circRNA) is a novel type of non-coding RNA, plays a vital role in the progression of tumors. The expression and function of circRNA in the GC immune microenvironment remain obscure. In this study, we utilized a bioinformatic analysis to construct a circRNA/microRNA (miRNA)/messenger RNA (mRNA) network involved in the progression and prognosis of GC. CircRNA DYRK1A_017, circRNA FLNA_118, miR-6512-3p, miR-6270-5p, and VCAN were identified as the key molecules in the hub regulatory axis. Dysregulation of this axis contributed to the cancer-associated signaling pathways (epithelial-mesenchymal transition [EMT], Nuclear factor kappa β-Tumor necrosis factor-α (NFκβ-TNFα) signaling, and angiogenesis) and aberrant immune microenvironment (infiltration by tumor associated macrophage, regulatory T cell, and mast cell). More importantly, the immunosuppressive tumor microenvironment may reveal the mechanism of novel circRNAs in tumors and serve as the target of immunotherapy.
- Published
- 2021
- Full Text
- View/download PDF